Implementation of a Structured Post-pulmonary Embolism Follow-up Model
Condition(s) studied
Investigational drug(s) / intervention(s)
Attend-PE model: A pulmonary embolism follow-up care model consisting of structured elements for follow-up after discharge from hospital.
Study summary
Venous thromboembolism (VTE), clinically presenting as deep vein thrombosis or pulmonary embolism (PE) is the third most frequent cardiovascular disease and is associated with substantial short- and long-term morbidity and mortality and high costs of care. In addition negative physical and mental complications following VTE are common. However in terms of PE, there are no structured follow-up programs in Denmark and there is considerable variation in practice patterns of post-PE management both within and between countries.
This project aims to develop, test and implement a structured follow-up care model for patients with PE (The Attend-PE model). This project is a pre-post intervention study and will estimate the effectiveness of implementing the structured follow-up care model on a national level.
Eligibility
Primary outcome measure(s)
- The Pulmonary Embolism Quality of Life (PEmb-QoL) questionnaire — 6 and 12 month follow-up
42 item covering health-related quality of life after pulmonary embolism. Transformed scale show score from 0-100, where 0 is the worst outcome and 100 is the best outcome. - Adherence to the anticoagulant treatment — within the first 6 and 12 months
Patients having redeemed ≥80% of the prescribed anticoagulant medication. Using The Danish National Prescription Registry.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Aalborg University Hospital | Aalborg | Denmark | Recruiting |
More Aalborg University Hospital trials in Denmark
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06037096 on ClinicalTrials.gov ↗ ← All trials in Denmark